Aminosalicylic Acids
- Use of old and new oral 5-aminosalicylic acid formulations in inflammatory bowel disease
Sulfasalazine, a 5-ASA agent, is the anti-inflammatory agent of choice for ulcerative colitis and Crohn's disease. Newer delayed-release formulations can also be appropriate first-line agents.